የH1B ደመወዝ መረጃ

መነሻ › ሙያዎች › Bioengineers and Biomedical Engineers › Irvine, CA

Bioengineers and Biomedical Engineers በIrvine፣ CA፡ የH-1B ደመወዞች

112 የሥራ ሁኔታ ማመልከቻዎች ለዚህ ሙያ ከሥራ ቦታ ጋር በIrvine፣ CA። መካከለኛ የቀረበ መሠረታዊ ደመወዝ $116,694፤ መካከለኛ ግማሽ $99,506–$133,310።

ማመልከቻዎች (LCAs)112
መካከለኛ የሚቀርብ ደመወዝ$116,694
የደመወዞች መካከለኛ ግማሽ$99,506–$133,310
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$77,965–$149,675

በደመወዝ ደረጃ

የደመወዝ ደረጃመካከለኛ ደመወዝ
ደረጃ I (መግቢያ)$85,675
ደረጃ II (ብቁ)$99,008
ደረጃ III (ልምድ ያለው)$121,000
ደረጃ IV (ሙሉ ብቃት ያለው)$136,140

የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።

አሠሪዎች

አሠሪLCAsመካከለኛ ደመወዝ
Edwards Lifesciences LLC17$120,078
Masimo Corporation17$121,000
Covidien LP12$112,684
Biosense Webster, Inc.9$125,100
University of California, Irvine5$71,632
Enterey, Inc.5$103,660
Diality, Inc.4$148,464
Becton, Dickinson and Company4$137,500
AbbVie Inc.3$133,500
Medtronic, Inc.2$123,782
Fluxergy, Inc.2$89,000
The Fountain Group, LLC2$135,200
Zymo Research Corporation2$95,838
Truabutment, Inc.2$71,906
Eurofins Electrical and Electronic Testing NA, LLC2$135,000
Advanced Sterilization Products, Inc.2$131,435
626Opco, LLC2$209,000
Masimo Americas, Inc.2$138,140
Invoy, LLC1$116,688
Cercacor Laboratories, Inc.1$77,646
CytoChip Inc1$85,000
Vyaire Medical, Inc.1$116,688
MP Biomedicals, LLC1$78,000
Cue Health, Inc.1$107,217
CSA America Testing & Certification, LLC1$120,000
Applied Medical Resources Corporation1$140,000
Tandem Diabetes Care, Inc.1$99,008
Innolcon Research, Inc.1$93,000
Meacor Inc.1$120,000
Magic Leap, Inc.1$225,000
Amplify Surgical, Inc.1$92,290
Populus Group LLC1$108,160
Planet Innovation, Inc.1$110,000
Hoya Surgical Optics, Inc.1$85,675
Medennium Inc1$86,000
Integra LifeSciences Corporation1$152,153

የሥራ መደቦች

H-1B ማገድያዎች በIrvine፣ CA →

ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።